NCT07577908

Brief Summary

This study aims to evaluate the effectiveness of Serratus Posterior Superior Intercostal Plane (SPSIP) block compared to Intercostal Nerve (ICN) block in terms of postoperative pain control, reduction of opioid analgesic consumption, minimization of postoperative respiratory complications, and increase patient satisfaction (using a 5-point Likert scale) in patients undergoing video-assisted thoracoscopic surgery (VATS).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
3mo left

Started May 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
May 2026Aug 2026

First Submitted

Initial submission to the registry

May 5, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 11, 2026

Completed
7 days until next milestone

Study Start

First participant enrolled

May 18, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Last Updated

May 20, 2026

Status Verified

May 1, 2026

Enrollment Period

3 months

First QC Date

May 5, 2026

Last Update Submit

May 18, 2026

Conditions

Keywords

Serratus posterior superior intercostal plane blockintercostal nerve blockVATS

Outcome Measures

Primary Outcomes (1)

  • Postoperative pain intensity

    In both study groups, postoperative pain intensity at rest and with coughing was measured using the Numerical Pain Rating Scale (NPRS), a numerical scale ranging from 0 to 10 (0 meaning no pain, 10 meaning the most severe pain imaginable).

    24 hours after the end of surgery

Secondary Outcomes (4)

  • Total opioid drug consumption

    24 hours after the end of surgery

  • Consumption of rescue analgesics

    24 hours after the end of surgery

  • Postoperative Complications

    24 hours after the end of surgery

  • Patient satisfaction score

    At the 24th hour post-operation

Study Arms (2)

Group SPSIP Block

In patients meeting the inclusion criteria for the study, an ultrasound-guided interfacial plane block is applied between the posterior superior serratus muscle and the underlying ribs in patients undergoing SPSIP block after VATS.

Group ICN Block

Patients meeting the inclusion criteria for the study who will undergo intercostal nerve block after VATS will have a total of 10 ml of 0.5% bupivacaine applied to two segments (upper and lower segments of the incision line) under direct vision by the surgeon while the patient is in the lateral decubitus position at the end of the operation and immediately before skin closure.

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who will undergo elective VATS surgery in the thoracic surgery operating room of Kocaeli City Hospital

You may qualify if:

  • Aged 18-80 years,
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Patients who have provided informed consent to participate in the study

You may not qualify if:

  • Patients who refuse to participate in the study by not signing the informed consent
  • Patients classified as ASA \> 3, according to the system established by the American Society of Anesthesiologists
  • Patients unable to understand the use of the NPR Scale or the PCA device that will be used for postoperative analgesia
  • Coagulation disorders or anticoagulant therapy contraindicating regional anesthesia
  • Patients with allergies to analgesic and/or anesthetic drugs
  • Infection at the block injection site
  • Patients whose surgical procedure is intraoperatively converted to an open pulmonary resection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kocaeli City Hospital

İzmit, Turkey (Türkiye)

RECRUITING

Related Publications (2)

  • Avci O, Gundogdu O, Balci F, Tekcan MN, Ozbey M. Efficacy of serratus posterior superior intercostal plane block (SPSIPB) on post-operative pain and total analgesic consumption in patients undergoing video-assisted thoracoscopic surgery (VATS): A double-blinded randomised controlled trial. Indian J Anaesth. 2023 Dec;67(12):1116-1122. doi: 10.4103/ija.ija_589_23. Epub 2023 Dec 13.

    PMID: 38343684BACKGROUND
  • Tulgar S, Ciftci B, Ahiskalioglu A, Bilal B, Sakul BU, Korkmaz AO, Bozkurt NN, De Cassai A, Torres AJ, Elsharkawy H, Alici HA. Serratus Posterior Superior Intercostal Plane Block: A Technical Report on the Description of a Novel Periparavertebral Block for Thoracic Pain. Cureus. 2023 Feb 3;15(2):e34582. doi: 10.7759/cureus.34582. eCollection 2023 Feb.

    PMID: 36883093BACKGROUND

Study Officials

  • Ayşe Z Turan Cıvraz, Assoc. Prof.

    Kocaeli City Hospital

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

May 5, 2026

First Posted

May 11, 2026

Study Start

May 18, 2026

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

May 20, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations